Nobel Prize winner wants to solve real-world problems with directed evolution

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2–specific data are lacking

Chemical makers and oil producers are pulling back on production, reconsidering investments

New study explores whether dampening IL-6 could address serious coronavirus infections

Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations

WHO does not recommend against taking the drug for fever caused by novel coronavirus infection

Boston biotech firm is making its discovery and production service available to firms working on diagnostics, treatments, and vaccines

NO₂ levels have fallen sharply in northern Italy and China

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2-specific data are lacking

Chemical makers, cleaning product firms, and cosmetics makers are all scrambling to meet new limits on the impurity

The US has a fraught history at the intersection of science and China relations

Many are FDA-approved drugs that could be repurposed

Italian workers threaten to strike, but German, UK companies and workers pull together

Old anti-malarial drugs have shown mixed results in the small clinical trials conducted so far

The nucleoside inhibitor has advantages over Gilead's remdesivir but has yet to be tested in humans

Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations

Gilead Sciences' antiviral is in multiple late-stage trials to treat coronavirus infections. Don't expect a home run, say infectious disease experts

Lingering logistic problems and a sputtering economy mean hard times for companies

With a diagnostic backlog hampering disease control efforts, scientists are turning to CRISPR and other technologies to bridge the gap

Drugmakers want to keep trials going but acknowledge that medical resources are strained

Lingering logistic problems and a sputtering economy mean hard times for companies

Editors in Europe and the US plan to work with authors whose lives and labs have been disrupted by the novel coronavirus

Fingers are being pointed in the Netherlands and the UK over reagent capacity constraints

Open-access collection contains nearly 50,000 chemical compounds from the CAS Registry

The chemist wants the Gates Foundation–backed institute to share its expertise during the coronavirus pandemic and advocate for public health

Regulators are restricting reusable bags over worries they might harbor virus

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease

Structural data on the complex could guide drug and vaccine design

Regulators are restricting reusable bags over worries they might harbor virus

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease

<i>Stereo Chemistry</i> reveals the surprising origin story of the engine that brought the Apollo 13 astronauts home and the man who designed it

Japanese government plans to buy at least 2 million tablets of the influenza drug

Some patients experience neurological, cardiovascular, and intestinal symptoms after infection with SARS-CoV-2

Early earnings figures from chemical makers are down

Tests of 10 or more novel vaccines could be underway by mid-May

Japanese government plans to buy at least 2 million courses of the influenza drug

COVID-19 is driving a fivefold or greater increase in demand

National labs, universities, and companies around the world are fast-tracking proposals to use their high-performance computer resources against the novel coronavirus

Lab tests form part of the evidence for investigation and identification team's report